Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Linda H. Martin"'
Autor:
Ohad S. Bentur, Jihong Li, Caroline S. Jiang, Linda H. Martin, Dean J. Kereiakes, Barry S. Coller
Publikováno v:
TH Open, Vol 05, Iss 03, Pp e449-e460 (2021)
Introduction Prehospital therapy of ST-elevation myocardial infarction (STEMI) with αIIbβ3 antagonists improves clinical outcomes, but they are difficult to use in prehospital settings. RUC-4 is a novel αIIbβ3 antagonist being developed for preho
Externí odkaz:
https://doaj.org/article/44739d156a174cadbbd7ae35ef38e4b8
Autor:
Dean J. Kereiakes, Tim D. Henry, Anthony N. DeMaria, Ohad Bentur, Marilyn Carlson, Corinne Seng Yue, Linda H. Martin, Jeff Midkiff, Michele Mueller, Terah Meek, Deborah Garza, C. Michael Gibson, Barry S. Coller
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 17 (2020)
Background Despite reductions in door‐to‐balloon times for primary coronary intervention, mortality from ST‐segment–elevation myocardial infarction has plateaued. Early pre–primary coronary intervention treatment of ST‐segment–elevation
Externí odkaz:
https://doaj.org/article/1929a15707574416aad6902e79d89e29
Autor:
C. Michael Gibson, Corinne Seng Yue, Tim Henry, Jeff Midkiff, Marilyn Carlson, Dean J. Kereiakes, Michele N. Mueller, Linda H. Martin, Ohad S. Bentur, Terah Meek, Barry S. Coller, Anthony N. DeMaria, Deborah Garza
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Despite reductions in door‐to‐balloon times for primary coronary intervention, mortality from ST‐segment–elevation myocardial infarction has plateaued. Early pre–primary coronary intervention treatment of ST‐segment–elevation
Autor:
Charles W. Abbottsmith, Thomas M. Shimshak, John F. Schneider, Dean J. Kereiakes, Thomas M. Broderick, Mark McDonald, Eli M. Roth, David D. Whang, Linda H. Martin, Wendy L. Howard
Publikováno v:
American Heart Journal. 139:s53-s60
Publikováno v:
American Heart Journal. 123:835-840
Substantial time delays from symptom onset to diagnosis and treatment of patients with acute myocardial infarction have been demonstrated. To determine the relative importance of prehospital mode of patient transport and the relative impact of emerge
Autor:
Eric J. Topol, Stephen G. Ellis, Dean J. Kereiakes, Barry S. George, Joseph Samaha, Richard S. Stack, Robert M. Califf, Linda H. Martin, Sharon Y. Young
Publikováno v:
American Heart Journal. 122:390-399
Coronary bypass surgery was performed prior to hospital discharge in 303 (22%) of 1387 consecutive patients enrolled in the TAMI 1 to 3 and 5 trials of intravenous thrombolytic therapy for acute myocardial infarction. Bypass surgery was of emergency
Autor:
Eric J. Topol, Stephen G. Ellis, Richard J. Candela, Linda H. Martin, Dean J. Kereiakes, Robert M. Califf, Richard S. Stack, Lynn Harrelson, Charles W. Abbottsmith, Barry S. George
Publikováno v:
Journal of the American College of Cardiology. 17(2):304-312
The incidence of minimal residual atherosclerotic coronary obstruction after successful intravenous thrombolytic therapy was evaluated in 799 patients with acute myocardial infarction. Minimal residual coronary obstruction (≤50%) was observed on se
Autor:
W. Brian Gibler, Jane D Blanton, Dean J. Kereiakes, Roy E. Erb, Sam L. Teichman, Charles W. Abbottsmith, Edward N. Dean, Linda H. Martin, Linda C. Anderson, Donald Blanton, John A. Morris, Clint D. Gibler
Publikováno v:
American Heart Journal. 121:1-11
Intravenous thrombolytic therapy improves left ventricular function and reduces mortality in patients with acute myocardial infarction (AMI). In European and Middle Eastern trials, prehospital delivery of thrombolytic agents by physician-directed mob
Autor:
Eric J. Topol, Lynne Aronson, Richard J. Candela, Linda H. Martin, Charles A. Abbottsmith, Barry S. George, William W. O'Neill, Robert M. Califf, Dean J. Kereiakes, Kerry L. Lee, Richard S. Stack, David B. Pryor
Publikováno v:
American Heart Journal. 119:777-785
To evaluate the long-term effects of reperfusion with tissue plasminogen activator (t-PA) and an aggressive strategy of revascularization with angioplasty and coronary artery bypass grafting, we obtained 1-year follow-up results from 386 consecutive
Autor:
Robert J. Anders, Linda H. Martin, Nancy A. Higby, Thomas M. Broderick, Dean J. Kereiakes, Neal S. Kleiman, Gary L. Hantsbarger, Shawn McDonald, James J. Ferguson, John Paul Runyon
Publikováno v:
Circulation. 96(4)
Background Inhibition of platelet aggregation with parenteral glycoprotein (GP) IIb/IIIa receptor blockers can reduce the ischemic complications of angioplasty. Sustained efficacy and safety of protracted GP IIb/IIIa blockade with an orally administe